Modifications of human growth differentiation factor 9 to improve the generation of embryos from low competence oocytes

Molecular Endocrinology

Volumn 29, Issue 1, 2015, Pages 40-52

  Li, Jing Jie ^a,d   Sugimura, Satoshi ^b,c,d   Mueller, Thomas D ^f   White, Melissa A ^d   Martin, Georgia A ^d   Ritter, Lesley J ^d   Liang, Xiao Yan ^a   Gilchrist, Robert B ^d,e   Mottershead, David G ^d  

^a SUN YAT SEN UNIVERSITY   (China)

^b Laboratory of Veterinary Molecular Pathology and Therapeutics Division of Animal Life Science Institute of Agriculture   (Japan)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHIMERIC PROTEIN; CHIMERIC PROTEIN M2; CHIMERIC PROTEIN M3; CHIMERIC PROTEIN M4; GROWTH DIFFERENTIATION FACTOR 9; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN 15; GDF9 PROTEIN, HUMAN; HYBRID PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BIOASSAY; BLASTOCYST; CUMULUS CELL; DEVELOPMENTAL COMPETENCE; DNA SYNTHESIS; EMBRYO; GENE EXPRESSION; GRANULOSA CELL; HUMAN; HUMAN CELL; HYDROGEN BOND; LIGAND BINDING; LOW COMPETENCE OOCYTE; MOLECULAR MODEL; MONOLAYER CULTURE; MOUSE; NONHUMAN; OOCYTE; OOCYTE MATURATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PORCINE MODEL; PRIORITY JOURNAL; PROTEIN MODIFICATION; RECEPTOR BINDING; STEREOSPECIFICITY; WESTERN BLOTTING; WILD TYPE; ANIMAL; ANIMAL EMBRYO; CELL LINE; CHEMICAL STRUCTURE; CYTOLOGY; FEMALE; FERTILIZATION IN VITRO; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; IN VITRO OOCYTE MATURATION; MALE; OOCYTE DEVELOPMENT; PHYSIOLOGY; PIG; PROCEDURES; SPERM; SPERMATOZOON;

SUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 15; CELL LINE; EMBRYO, MAMMALIAN; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELLS; GROWTH DIFFERENTIATION FACTOR 9; HEK293 CELLS; HUMANS; IN VITRO OOCYTE MATURATION TECHNIQUES; MALE; MICE; MODELS, MOLECULAR; OOCYTES; OOGENESIS; RECOMBINANT FUSION PROTEINS; SEMEN; SPERMATOZOA; SUS SCROFA;

EID: 84922291637     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1173     Document Type: Article

References (75)

1. Wang XL, Wang K, Zhao S, Wu Y, Gao H, Zeng SM. Oocytesecreted growth differentiation factor 9 inhibits BCL-2-interacting mediator of cell death-extra long expression in porcine cumulus cell. Biol Reprod. 2013;89:56.
2. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci USA. 2002;99:2890-2894.
3. Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update. 2008;14:159-177.
4. Downs SM, Utecht AM. Metabolism of radiolabeled glucose by mouse oocytes and oocyte-cumulus cell complexes. Biol Reprod. 1999;60:1446-1452.
5. Gilchrist RB, Ritter LJ, Myllymaa S, et al. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation. J Cell Sci. 2006;119:3811-3821.
6. Dragovic RA, Ritter LJ, Schulz SJ, Amato F, Armstrong DT, Gilchrist RB. Role of oocyte-secreted growth differentiation factor 9 in the regulation of mouse cumulus expansion. Endocrinology. 2005; 146:2798-2806.
7. Elvin JA, Yan C, Matzuk MM. Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway. Proc Natl Acad Sci USA. 2000; 97:10288-10293.
8. Vanderhyden BC, Cohen JN, Morley P. Mouse oocytes regulate granulosa cell steroidogenesis. Endocrinology. 1993;133:423-426.
9. Sutton-McDowall ML, Mottershead DG, Gardner DK, Gilchrist RB, Thompson JG. Metabolic differences in bovine cumulusoocyte complexes matured in vitro in the presence or absence of follicle-stimulating hormone and bone morphogenetic protein 15. Biol Reprod. 2012;87:87.
10. Su YQ, Sugiura K, Wigglesworth K, et al. Oocyte regulation of metabolic cooperativity between mouse cumulus cells and oocytes: BMP15 and GDF9 control cholesterol biosynthesis in cumulus cells. Development. 2008;135:111-121.
11. Eppig JJ, Wigglesworth K, Pendola F, Hirao Y. Murine oocytes suppress expression of luteinizing hormone receptor messenger ribonucleic acid by granulosa cells. Biol Reprod. 1997;56:976-984.
12. Orisaka M, Orisaka S, Jiang JY, et al. Growth differentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage. Mol Endocrinol. 2006;20:2456-2468.
13. Hussein TS, Froiland DA, Amato F, Thompson JG, Gilchrist RB. Oocytes prevent cumulus cell apoptosis by maintaining a morphogenic paracrine gradient of bone morphogenetic proteins. J Cell Sci. 2005;118:5257-5268.
14. Wang TT, Ke ZH, Song Y, et al. Identification of a mutation in GDF9 as a novel cause of diminished ovarian reserve in young women. Hum Reprod. 2013;28:2473-2481.
15. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol. 1999;13:1035-1048.
16. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, MatzukMM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 1996;383:531-535.
17. Simpson CM, Robertson DM, Al-Musawi SL, et al. Aberrant GDF9 expression and activation are associated with common human ovarian disorders. J Clin Endocrinol Metab. 2014;99:E615-E624.
18. Hanrahan JP, Gregan SM, Mulsant P, et al. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod. 2004;70:900-909.
19. Wang TT, Wu YT, Dong MY, Sheng JZ, Leung PC, Huang HF. G546A polymorphism of growth differentiation factor-9 contributes to the poor outcome of ovarian stimulation in women with diminished ovarian reserve. Fertil Steril. 2010;94:2490-2492.
20. Chand AL, Ponnampalam AP, Harris SE, Winship IM, Shelling AN. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril. 2006;86:1009-1012.
21. Dixit H, Rao LK, Padmalatha V, et al. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause. 2005;12:749-754.
22. Teixeira Filho F, Baracat EC, Lee TH, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:1337-1344.
23. Wang B, Zhou S, Wang J, et al. Identification of novel missense mutations of GDF9 in Chinese women with polycystic ovary syndrome. Reprod Biomed Online. 2010;21:344-348.
24. Palmer JS, Zhao ZZ, Hoekstra C, et al. Novel variants in growth differentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab. 2006;91:4713-4716.
25. Montgomery GW, Zhao ZZ, Marsh AJ, et al. A deletion mutation in GDF9 in sisters with spontaneous DZ twins. Twin Res. 2004;7: 548-555.
26. McPherron AC, Lee SJ. GDF-3 and GDF-9: two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines. J Biol Chem. 1993;268:3444-3449.
27. Hayashi M, McGee EA, Min G, et al. Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology. 1999;140:1236- 1244.
28. Mottershead DG, Pulkki MM, Muggalla P, et al. Characterization of recombinant human growth differentiation factor-9 signaling in ovarian granulosa cells. Mol Cell Endocrinol. 2008;283:58-67.
29. Gilchrist RB, Ritter LJ, Cranfield M, et al. Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity. Biol Reprod. 2004;71:732-739.
30. McNatty KP, Lawrence S, Groome NP, et al. Meat and Livestock Association Plenary Lecture 2005. Oocyte signalling molecules and their effects on reproduction in ruminants. Reprod Fertil Dev. 2006;18:403-412.
31. Simpson CM, Stanton PG, Walton KL, et al. Activation of latent human GDF9 by a single residue change (Gly391Arg) in the mature domain. Endocrinology. 2012;153:1301-1310.
32. Harrison CA, Al-Musawi SL, Walton KL. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands. Growth Factors. 2011;29:174-186.
33. Watson LN, Mottershead DG, Dunning KR, Robker RL, Gilchrist RB, Russell DL. Heparan sulfate proteoglycans regulate responses to oocyte paracrine signals in ovarian follicle morphogenesis. Endocrinology. 2012;153:4544-4555.
34. Gremeau AS, Andreadis N, Fatum M, et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A casecontrol study of 194 treatment cycles. Fertil Steril. 2012;98:355- 360.
35. Mester B, Ritter LJ, Pitman JL, et al. Oocyte expression, secretion and somatic cell interaction of mouse bone morphogenetic protein 15 during the peri-ovulatory period [published online ahead of print February 19, 2014]. Reprod Fertil Dev.
36. Hussein TS, Thompson JG, Gilchrist RB. Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol. 2006;296: 514-521.
37. Hussein TS, Sutton-McDowall ML, Gilchrist RB, Thompson JG. Temporal effects of exogenous oocyte-secreted factors on bovine oocyte developmental competence during IVM. Reprod Fertil Dev. 2011;23:576-584.
38. Yeo CX, Gilchrist RB, Thompson JG, Lane M. Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice. Hum Reprod. 2008;23:67-73.
39. Romaguera R, Morató R, Jiménez-Macedo AR, et al. Oocyte secreted factors improve embryo developmental competence of COCs from small follicles in prepubertal goats. Theriogenology. 2010;74:1050-1059.
40. Sudiman J, Ritter LJ, Feil DK, et al. Effects of differing oocytesecreted factors during mouse in vitro maturation on subsequent embryo and fetal development. J Assist Reprod Genet. 2014;31: 295-306.
41. Dey SR, Deb GK, Ha AN, et al. Coculturing denuded oocytes during the in vitro maturation of bovine cumulus oocyte complexes exerts a synergistic effect on embryo development. Theriogenology. 2012;77:1064-1077.
42. Gomez MN, Kang JT, Koo OJ, et al. Effect of oocyte-secreted factors on porcine in vitro maturation, cumulus expansion and developmental competence of parthenotes. Zygote. 2012;20:135- 145.
43. Hobbs S, Jitrapakdee S, Wallace JC. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1α promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun. 1998;252:368-372.
44. Marchal R, Vigneron C, Perreau C, Bali-Papp A, Mermillod P. Effect of follicular size on meiotic and developmental competence of porcine oocytes. Theriogenology. 2002;57:1523-1532.
45. Quinn P, Barros C, Whittingham DG. Preservation of hamster oocytes to assay the fertilizing capacity of human spermatozoa. J Reprod Fertil. 1982;66:161-168.
46. Yoshioka K, Suzuki C, Onishi A. Defined system for in vitro production of porcine embryos using a single basic medium. J Reprod Dev. 2008;54:208-213.
47. Procházka R, Petlach M, Nagyová E, Nemcová L. Effect of epidermal growth factor-like peptides on pig cumulus cell expansion, oocyte maturation, and acquisition of developmental competence in vitro: comparison with gonadotropins. Reproduction. 2011;141: 425-435.
48. Vanderhyden BC, Caron PJ, Buccione R, Eppig JJ. Developmental pattern of the secretion of cumulus expansion-enabling factor by mouse oocytes and the role of oocytes in promoting granulosa cell differentiation. Dev Biol. 1990;140:307-317.
49. Fagbohun CF, Downs SM. Maturation of the mouse oocyte-cumulus cell complex: stimulation by lectins. Biol Reprod. 1990;42:413- 423.
50. Miyoshi K, Umezu M, Sato E. Effect of hyaluronic acid on the development of porcine 1-cell embryos produced by a conventional or new in vitro maturation/fertilization system. Theriogenology. 1999;51:777-784.
51. Suzuki C, Iwamura S, Yoshioka K. Birth of piglets through the non-surgical transfer of blastocysts produced in vitro. J Reprod Dev. 2004;50:487-491.
52. Gilchrist RB, Ritter LJ. Differences in the participation of TGFB superfamily signalling pathways mediating porcine and murine cumulus cell expansion. Reproduction. 2011;142:647-657.
53. Shi M, Zhu J, Wang R, et al. Latent TGF-β structure and activation. Nature. 2011;474:343-349.
54. Weber D, Kotzsch A, Nickel J, et al. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor. BMC Struct Biol. 2007;7:6.
55. Scheufler C, Sebald W, Hülsmeyer M. Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. J Mol Biol. 1999;287:103-115.
56. Pulkki MM, Myllymaa S, Pasternack A, et al. The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region. Mol Cell Endocrinol. 2011;332:106-115.
57. Pulkki MM, Mottershead DG, Pasternack AH, et al. A covalently dimerized recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor type 1B as a key cell surface receptor on ovarian granulosa cells. Endocrinology. 2012;153:1509-1518.
58. Van den Abbeel E, Balaban B, Ziebe S, et al. Association between blastocyst morphology and outcome of single-blastocyst transfer. Reprod Biomed Online. 2013;27:353-361.
59. Das ZC, Gupta MK, Uhm SJ, Lee HT. Supplementation of insulintransferrin- selenium to embryo culture medium improves the in vitro development of pig embryos. Zygote. 2014;22:411-418.
60. Keller S, Nickel J, Zhang JL, Sebald W, Mueller TD. Molecular recognition of BMP-2 and BMP receptor IA. Nat Struct Mol Biol. 2004;11:481-488.
61. Kirsch T, Nickel J, Sebald W. BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPRII. EMBO J. 2000;19:3314-3324.
62. Kirsch T, Sebald W, Dreyer MK. Crystal structure of the BMP-2- BRIA ectodomain complex. Nat Struct Biol. 2000;7:492-496.
63. Kotzsch A, Nickel J, Seher A, et al. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome. J Biol Chem. 2008;283:5876-5887.
64. Nickel J, Kotzsch A, Sebald W, Mueller TD. A single residue of GDF-5 defines binding specificity to BMP receptor IB. J Mol Biol. 2005;349:933-947.
65. Tibaldi E, Arrigoni G, Martinez HM, Inagaki K, Shimasaki S, Pinna LA. Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9. FEBS Lett. 2010;584:801-805.
66. McMahon HE, Sharma S, Shimasaki S. Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor-9 plays a critical role in determining agonistic or antagonistic functions. Endocrinology. 2008;149:812-817.
67. Lamazou F, Legouez A, Letouzey V, et al. Ovarian hyperstimulation syndrome: pathophysiology, risk factors, prevention, diagnosis and treatment. J Gynecol Obstet Biol Reprod (Paris). 2011;40: 593-611. french
68. Fatemi HM, Popovic-Todorovic B. Implantation in assisted reproduction: a look at endometrial receptivity. Reprod Biomed Online. 2013;27:530-538.
69. McNatty KP, Juengel JL, Reader KL, et al. Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction. 2005;129: 481-487.
70. Shi FT, Cheung AP, Leung PC. Growth differentiation factor 9 enhances activin a-induced inhibin B production in human granulosa cells. Endocrinology. 2009;150:3540-3546.
71. Huang Q, Cheung AP, Zhang Y, Huang HF, Auersperg N, Leung PC. Effects of growth differentiation factor 9 on cell cycle regulators and ERK42/44 in human granulosa cell proliferation. Am J Physiol Endocrinol Metab. 2009;296:E1344-E1353.
72. Mottershead DG, Watson AJ. Oocyte peptides as paracrine tools for ovarian stimulation and oocyte maturation. Mol Hum Reprod. 2009;15:789-794.
73. Sudiman J, Sutton-McDowall ML, Ritter LJ, et al. Bone morphogenetic protein 15 in the pro-mature complex form enhances bovine oocyte developmental competence. PLoS One. 2014;9:e103563.
74. Sugimura S, Ritter LJ, Sutton-McDowall ML, Mottershead DG, Thompson JG, Gilchrist RB. Amphiregulin co-operates with bone morphogenetic protein 15 to increase bovine oocyte developmental competence: effects on gap junction-mediated metabolite supply. Mol Hum Reprod. 2014;20:499-513.
75. Nogueira D, Sadeu JC, Montagut J. In vitro oocyte maturation: current status. Semin Reprod Med. 2012;30:199-213.